Congress Park Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,101
| Closed | -$648K | – | 120 |
|
|
2023
Q2 | $648K | Sell |
5,101
-75
| -1% | -$9.52K | 0.32% | 66 |
|
|
2023
Q1 | $669K | Sell |
5,176
-705
| -12% | -$91.1K | 0.35% | 61 |
|
|
2022
Q4 | $772K | Sell |
5,881
-320
| -5% | -$42K | 0.45% | 55 |
|
|
2022
Q3 | $725K | Sell |
6,201
-30
| -0.5% | -$3.51K | 0.42% | 50 |
|
|
2022
Q2 | $733K | Sell |
6,231
-1,195
| -16% | -$141K | 0.45% | 57 |
|
|
2022
Q1 | $968K | Sell |
7,426
-1,015
| -12% | -$132K | 0.49% | 53 |
|
|
2021
Q4 | $1.29M | Buy |
8,441
+677
| +9% | +$103K | 0.63% | 41 |
|
|
2021
Q3 | $1.26M | Buy |
7,764
+2,810
| +57% | +$454K | 0.64% | 45 |
|
|
2021
Q2 | $811K | Buy |
4,954
+406
| +9% | +$66.5K | 0.41% | 58 |
|
|
2021
Q1 | $685K | Buy |
4,548
+455
| +11% | +$68.5K | 0.38% | 64 |
|
|
2020
Q4 | $620K | Buy |
4,093
+1,336
| +48% | +$202K | 0.37% | 59 |
|
|
2020
Q3 | $373K | Buy |
2,757
+400
| +17% | +$54.1K | 0.23% | 67 |
|
|
2020
Q2 | $322K | Buy |
+2,357
| New | +$322K | 0.25% | 72 |
|